Chemed Corporation (CHE) — Fair Value Analysis
Base-case fair value (P50): $530.10 · Current price: $532.25 · Verdict: Fairly Valued
The Verdict on CHE
CHEMED CORP (CHE) is currently assessed as Fairly Valued based on our proprietary Monte Carlo simulations. The current trading price of $532.25 aligns remarkably closely with our calculated median fair value (P50) of $530.10. This narrow convergence results in a minimal -0.4% difference, indicating that the market is largely reflecting CHE's intrinsic value according to our models. Investors should note this tight correlation, which suggests limited immediate price dislocation from current levels.
How CHE stacks up against peers
While a specific sector isn't provided for direct peer comparison, CHEMED CORP's fundamental strength provides a solid anchor for its valuation. The company boasts a strong quality tier, reflecting robust operational and financial health. This underlying resilience supports the current market price of $532.25 and the computed median fair value of $530.10. A strong quality tier suggests that CHE's business fundamentals are well-regarded, justifying its present valuation and indicating a stable foundation even without direct peer metrics.
What this means for investors
For investors considering CHEMED CORP, the current "Fairly Valued" verdict implies that the stock may not offer substantial short-term arbitrage opportunities. With $532.25 tracking so closely to the $530.10, the -0.4% indicates minimal potential upside from this specific fair value estimate. Investors might instead focus on the company's strong quality tier as a sign of operational stability and long-term viability.
While the median fair value suggests limited immediate -0.4%, deeper analysis via FairCurve reveals the full spectrum of potential outcomes from our Monte Carlo simulations. This allows investors to understand the probabilities associated with various bear and bull case scenarios. Sign up for FairCurve to see the full bear/bull distribution and track CHE's fair value as new fundamentals are released.
Frequently Asked Questions
Is CHE overvalued or undervalued right now?
CHEMED CORP (CHE) is currently considered fairly valued, as its current price of $532.25 is very close to FairCurve's median fair value estimate of $530.10.
What is the bear case and bull case for CHE?
The full Monte Carlo distribution, including bear (P10) and bull (P90) target prices, along with the probability of upside, is available with a free FairCurve account. We do not provide specific dollar values here.
How does FairCurve calculate CHE's fair value?
FairCurve calculates CHE's fair value using sophisticated Monte Carlo simulations that model thousands of forward scenarios to determine a probabilistic range of outcomes and a median fair value.
How can I track CHE's fair value as it changes?
You can add CHEMED CORP to a free FairCurve watchlist for daily fair-value updates. FairCurve will also instantly re-value CHE when new earnings or significant fundamental data are released.